{"title":"Péptidos GLP-1 México","description":"\u003cp\u003eLos péptidos GLP-1 para investigación en México están disponibles en MVLabs con los más altos estándares de pureza del mercado. Nuestra colección incluye los péptidos agonistas del receptor GLP-1 más investigados actualmente, desde semaglutide hasta el triple agonista retatrutide.\u003c\/p\u003e\n\u003cp\u003e¿Qué son los péptidos GLP-1?\u003c\/p\u003e\n\u003cp\u003eLos péptidos GLP-1 (Glucagon-Like Peptide-1) son análogos sintéticos de la hormona intestinal GLP-1, la cual juega un papel fundamental en la regulación del metabolismo energético, la secreción de insulina dependiente de glucosa y el control del apetito. Los agonistas del receptor GLP-1 han sido objeto de intensa investigación científica en los últimos años, con estudios que exploran su papel en el metabolismo de carbohidratos, la composición corporal y la salud cardiovascular.\u003c\/p\u003e\n\u003cp\u003ePéptidos GLP-1 disponibles en México — MVLabs\u003c\/p\u003e\n\u003cp\u003eRetatrutide (Triple Agonista) — Actúa sobre receptores GLP-1, GIP y glucagón simultáneamente. El péptido más avanzado en investigación metabólica actual.\u003c\/p\u003e\n\u003cp\u003eSemaglutide — Agonista GLP-1 de acción prolongada. Uno de los péptidos más estudiados en investigación sobre metabolismo y composición corporal.\u003c\/p\u003e\n\u003cp\u003eTirzepatide — Agonista dual GLP-1\/GIP. Representó un avance significativo al combinar dos vías de señalización metabólica.\u003c\/p\u003e\n\u003cp\u003eCagrilintide — Análogo de amilina que se investiga en combinación con semaglutide (cagrisema) para efectos sinérgicos en investigación metabólica.\u003c\/p\u003e\n\u003cp\u003eCJC-1295 — Péptido que estimula la secreción de hormona de crecimiento, investigado en el contexto de composición corporal y metabolismo.\u003c\/p\u003e\n\u003cp\u003ePureza y Verificación — Estándar MVLabs\u003c\/p\u003e\n\u003cp\u003eTodos nuestros péptidos GLP-1 cuentan con certificado de pureza ≥99% por análisis HPLC y verificación individual por código QR. Esto garantiza que el investigador o profesional de salud recibe exactamente el compuesto especificado, sin adulteraciones ni contaminantes.\u003c\/p\u003e\n\u003cp\u003eEnvío discreto a todo México en 3-5 días hábiles. Solo para uso en investigación. Research Use Only (RUO). MVLabs.mx\u003c\/p\u003e","products":[{"product_id":"retatrutide","title":"Retatrutide","description":"\u003cp\u003e \u003c\/p\u003e\n\u003cdiv style=\"max-width: 760px; margin: auto; background: #fff; border: 1px solid #DCE1E6; border-radius: 18px; padding: 22px;\"\u003e\u003c!-- ===== product body_html (scoped .mvd) ===== --\u003e\u003c\/div\u003e\n\u003cstyle\u003e\n.mvd{font-family:Satoshi,system-ui,sans-serif;color:#13242a;line-height:1.62;font-size:15px}.mvd *{box-sizing:border-box}\n.mvd__chips{display:flex;flex-wrap:wrap;gap:8px;margin:0 0 22px}\n.mvd__chip{display:inline-flex;align-items:center;gap:7px;background:#e7f1f3;color:#0B6675;font-family:\"JetBrains Mono\",monospace;font-size:12px;font-weight:500;padding:7px 12px;border-radius:100px}.mvd__chip b{color:#0E8294}.mvd__chip--ruo{background:#13242a;color:#cfe8ec}\n.mvd__hero{display:flex;gap:16px;align-items:center;background:linear-gradient(120deg,#f4fafb,#eaf3f4);border:1px solid #d8e6e8;border-radius:16px;padding:16px 20px;margin:0 0 24px}.mvd__hero svg{flex:0 0 auto}.mvd__hero p{margin:0;font-size:14.5px;color:#3a4f56}\n.mvd section{margin:0 0 22px}.mvd__h{display:flex;align-items:center;gap:9px;margin:0 0 9px}.mvd__h svg{flex:0 0 auto;color:#0E8294}.mvd__h h3{font-family:\"Cabinet Grotesk\",sans-serif;font-weight:800;font-size:17px;margin:0;letter-spacing:-.01em}\n.mvd ul{margin:6px 0 0;padding:0;list-style:none;display:grid;gap:7px}.mvd ul li{position:relative;padding-left:20px;font-size:14.5px;color:#33474e}.mvd ul li::before{content:\"\";position:absolute;left:2px;top:8px;width:7px;height:7px;border-radius:50%;background:#15a0b4}\n.mvd p{margin:0 0 10px}\n.mvd__btn{display:inline-flex;align-items:center;gap:8px;background:#0E8294;color:#fff;font-weight:700;text-decoration:none;padding:11px 18px;border-radius:100px;font-size:14px;margin-top:4px}\n.mvd__note{background:#fbfcfd;border:1px solid #e3e9ec;border-radius:14px;padding:16px 18px;font-size:13.5px;color:#51646B}.mvd__note strong{color:#13242a}\n.mvd__cmp{display:grid;gap:11px;margin:4px 0 12px}.mvd__cmprow{display:grid;grid-template-columns:135px 1fr 52px;align-items:center;gap:12px}.mvd__cmpname{font-size:13px;font-weight:700;color:#13242a}.mvd__cmpname small{display:block;font-weight:500;color:#7c8a90;font-size:10.5px;font-family:\"JetBrains Mono\",monospace}.mvd__cmptrack{height:13px;border-radius:100px;background:#e7f1f3;overflow:hidden}.mvd__cmpfill{height:100%;border-radius:100px;background:linear-gradient(90deg,#0E8294,#15a0b4)}.mvd__cmprow--muted .mvd__cmpfill{background:#aac9d0}.mvd__cmpval{font-family:\"JetBrains Mono\",monospace;font-weight:500;font-size:13px;color:#0B6675;text-align:right}.mvd__src{font-size:11.5px;color:#809096;margin-top:-2px}\n.mvd__tip{display:flex;gap:11px;align-items:flex-start;background:#eef7f8;border:1px solid #d3e7ea;border-radius:13px;padding:13px 15px;margin:12px 0 4px;font-size:13px;color:#33474e;line-height:1.55}.mvd__tip svg{flex:0 0 auto;color:#0E8294;margin-top:1px}.mvd__tip p{margin:0}.mvd__tip strong{color:#0B6675}.mvd__tip b{background:#0E8294;color:#fff;font-family:\"JetBrains Mono\",monospace;font-size:11.5px;padding:2px 8px;border-radius:100px;white-space:nowrap}\n.mvd__tbl{width:100%;border-collapse:collapse;margin:4px 0 8px;font-size:13.5px}.mvd__tbl th{text-align:left;font-family:\"JetBrains Mono\",monospace;font-size:10.5px;letter-spacing:.04em;text-transform:uppercase;color:#0E8294;font-weight:600;padding:8px 10px;border-bottom:1px solid #d8e6e8}.mvd__tbl td{padding:9px 10px;border-bottom:1px solid #eef3f4;color:#33474e}.mvd__tbl tr:last-child td{border-bottom:0}.mvd__tbl td b{color:#13242a}.mvd__tbl tr.is-hi td{background:#f1f9fa}\n.mvd__refs{margin:4px 0 0;padding:0;list-style:none;display:grid;gap:9px;counter-reset:r}.mvd__refs li{font-size:12.5px;color:#51646B;padding-left:22px;position:relative;line-height:1.5}.mvd__refs li::before{content:counter(r);counter-increment:r;position:absolute;left:0;top:1px;width:15px;height:15px;border-radius:50%;background:#e7f1f3;color:#0B6675;font-family:\"JetBrains Mono\",monospace;font-size:9.5px;font-weight:600;display:grid;place-items:center}.mvd__refs a{color:#0E8294;font-weight:600}\n\u003c\/style\u003e\n\u003cdiv style=\"max-width: 760px; margin: auto; background: #fff; border: 1px solid #DCE1E6; border-radius: 18px; padding: 22px;\"\u003e\n\u003cdiv class=\"mvd\"\u003e\n\u003cdiv class=\"mvd__chips\"\u003e\n\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003ePurity\u003c\/b\u003e ≥98.7% HPLC\u003c\/span\u003e \u003cspan class=\"mvd__chip\"\u003e\u003cb\u003eFormat\u003c\/b\u003e Lyophilized powder\u003c\/span\u003e \u003cspan class=\"mvd__chip\"\u003e\u003cb\u003e10 mg \/ vial\u003c\/b\u003e\u003c\/span\u003e \u003cspan class=\"mvd__chip\"\u003e\u003cb\u003eSKU\u003c\/b\u003e RT10\u003c\/span\u003e \u003cspan class=\"mvd__chip mvd__chip--ruo\"\u003eResearch use only\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"mvd__hero\"\u003e\n\u003csvg width=\"90\" height=\"62\" viewbox=\"0 0 90 62\" fill=\"none\"\u003e\u003ccircle cx=\"15\" cy=\"14\" r=\"9\" fill=\"#0E8294\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"15\" cy=\"48\" r=\"9\" fill=\"#15a0b4\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"44\" cy=\"31\" r=\"10\" fill=\"#0B6675\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"74\" cy=\"31\" r=\"8\" fill=\"none\" stroke=\"#0E8294\" stroke-width=\"2.4\" stroke-dasharray=\"3 3\"\u003e\u003c\/circle\u003e\u003cpath d=\"M24 17 35 28M24 45 35 34M54 31H66\" stroke=\"#9cc6cd\" stroke-width=\"2\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\n\u003cp\u003eStudied across metabolic and energy-balance pathways.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003csection\u003e\n\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003ccircle cx=\"12\" cy=\"12\" r=\"9\"\u003e\u003c\/circle\u003e\u003cpath d=\"M12 7v10M7 12h10\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\n\u003ch3\u003eOverview\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eRetatrutide is an investigational peptide studied in metabolic research. It is designed as a \u003cstrong\u003etriple receptor agonist\u003c\/strong\u003e, interacting simultaneously with three key pathways of metabolic regulation: the GLP-1 receptor (glucagon-like peptide-1), the GIP receptor (glucose-dependent insulinotropic polypeptide) and the glucagon receptor. Because it engages all three at once, it is described in the literature as a \"triple agonist.\" It remains under clinical investigation and is not approved as a pharmaceutical product.\u003c\/p\u003e\n\u003c\/section\u003e\n\u003csection\u003e\n\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M9 3v6l-5 9a2 2 0 0 0 2 3h12a2 2 0 0 0 2-3l-5-9V3\"\u003e\u003c\/path\u003e\u003cpath d=\"M8 3h8\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\n\u003ch3\u003eResearch applications\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003eMetabolic regulation and energy-balance mechanisms\u003c\/li\u003e\n\u003cli\u003eGlucose homeostasis and insulin secretion research\u003c\/li\u003e\n\u003cli\u003eAppetite and satiety signaling pathway studies\u003c\/li\u003e\n\u003cli\u003eObesity and metabolic-disorder research models\u003c\/li\u003e\n\u003cli\u003eTriple-agonist pharmacology vs. single\/dual GLP-1\/GIP compounds\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/section\u003e\n\u003csection\u003e\n\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M3 21V10M9 21V4M15 21v-8M21 21V8\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\n\u003ch3\u003eComparative research data\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIn published clinical research, retatrutide produced the largest mean body-weight reduction among the leading incretin-based compounds. Figures below come from separate trials (not head-to-head):\u003c\/p\u003e\n\u003cdiv class=\"mvd__cmp\"\u003e\n\u003cdiv class=\"mvd__cmprow\"\u003e\n\u003cdiv class=\"mvd__cmpname\"\u003eRetatrutide\u003csmall\u003e12 mg · 48 wk\u003c\/small\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"mvd__cmptrack\"\u003e\n\u003cdiv class=\"mvd__cmpfill\" style=\"width: 100%;\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"mvd__cmpval\"\u003e~24%\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"mvd__cmprow mvd__cmprow--muted\"\u003e\n\u003cdiv class=\"mvd__cmpname\"\u003eTirzepatide\u003csmall\u003e15 mg · 72 wk\u003c\/small\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"mvd__cmptrack\"\u003e\n\u003cdiv class=\"mvd__cmpfill\" style=\"width: 93%;\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"mvd__cmpval\"\u003e~22.5%\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"mvd__cmprow mvd__cmprow--muted\"\u003e\n\u003cdiv class=\"mvd__cmpname\"\u003eSemaglutide\u003csmall\u003e2.4 mg · 68 wk\u003c\/small\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"mvd__cmptrack\"\u003e\n\u003cdiv class=\"mvd__cmpfill\" style=\"width: 62%;\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"mvd__cmpval\"\u003e~15%\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection\u003e\n\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003crect x=\"4\" y=\"3\" width=\"16\" height=\"18\" rx=\"2\"\u003e\u003c\/rect\u003e\u003cpath d=\"M8 8h8M8 12h8M8 16h5\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\n\u003ch3\u003eResearch dosing reference\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eExample weekly escalation in 2-week steps, with draw volumes for a \u003cstrong\u003e10 mg vial reconstituted in 2 mL\u003c\/strong\u003e bacteriostatic water (5 mg\/mL). Adjust any volume with the calculator. Dose levels up to 12 mg were evaluated in the phase-2 trial.\u003c\/p\u003e\n\u003ctable class=\"mvd__tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eWeek\u003c\/th\u003e\n\u003cth\u003eWeekly dose\u003c\/th\u003e\n\u003cth\u003eVolume @5 mg\/mL\u003c\/th\u003e\n\u003cth\u003eU-100 units\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e1–2\u003c\/td\u003e\n\u003ctd\u003e\u003cb\u003e0.5 mg\u003c\/b\u003e\u003c\/td\u003e\n\u003ctd\u003e0.10 mL\u003c\/td\u003e\n\u003ctd\u003e10 u\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3–4\u003c\/td\u003e\n\u003ctd\u003e\u003cb\u003e1 mg\u003c\/b\u003e\u003c\/td\u003e\n\u003ctd\u003e0.20 mL\u003c\/td\u003e\n\u003ctd\u003e20 u\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5–6\u003c\/td\u003e\n\u003ctd\u003e\u003cb\u003e1.5 mg\u003c\/b\u003e\u003c\/td\u003e\n\u003ctd\u003e0.30 mL\u003c\/td\u003e\n\u003ctd\u003e30 u\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7–8\u003c\/td\u003e\n\u003ctd\u003e\u003cb\u003e2 mg\u003c\/b\u003e\u003c\/td\u003e\n\u003ctd\u003e0.40 mL\u003c\/td\u003e\n\u003ctd\u003e40 u\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9–10\u003c\/td\u003e\n\u003ctd\u003e\u003cb\u003e3 mg\u003c\/b\u003e\u003c\/td\u003e\n\u003ctd\u003e0.60 mL\u003c\/td\u003e\n\u003ctd\u003e60 u\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11–12\u003c\/td\u003e\n\u003ctd\u003e\u003cb\u003e4 mg\u003c\/b\u003e\u003c\/td\u003e\n\u003ctd\u003e0.80 mL\u003c\/td\u003e\n\u003ctd\u003e80 u\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"is-hi\"\u003e\n\u003ctd\u003e13+\u003c\/td\u003e\n\u003ctd\u003e\u003cb\u003e4–8 mg\u003c\/b\u003e\u003c\/td\u003e\n\u003ctd\u003e0.80–1.60 mL\u003c\/td\u003e\n\u003ctd\u003e80–160 u\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp class=\"mvd__src\"\u003eIllustrative escalation for research reference only — not dosing guidance for human use. Levels up to 12 mg were studied (Jastreboff et al., 2023). Use the calculator for other vial sizes or reconstitution volumes.\u003c\/p\u003e\n\u003cdiv class=\"mvd__tip\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003ccircle cx=\"12\" cy=\"12\" r=\"9\"\u003e\u003c\/circle\u003e\u003cpath d=\"M12 8v5M12 16h.01\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\n\u003cp\u003e\u003cstrong\u003eCommunity note:\u003c\/strong\u003e Informal reports from fitness and research-oriented communities suggest that some users experiment with lower-dose, maintenance-style approaches rather than increasing toward the upper ranges evaluated in clinical studies. Ranges around \u003cb\u003e1–2 mg\u003c\/b\u003e weekly are commonly mentioned anecdotally; however, these reports are not clinical evidence and should not be interpreted as dosing guidance, a standardized protocol, or confirmation of long-term safety.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003ca class=\"mvd__btn\" href=\"https:\/\/mvlabs.mx\/pages\/calculadora-de-peptidos\" target=\"_blank\"\u003eOpen the peptide calculator →\u003c\/a\u003e\u003c\/section\u003e\n\u003csection\u003e\n\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M12 2v6M12 8 7 18a2 2 0 0 0 2 3h6a2 2 0 0 0 2-3z\"\u003e\u003c\/path\u003e\u003cpath d=\"M8.5 14h7\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\n\u003ch3\u003eHandling \u0026amp; storage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSupplied as a lyophilized powder. Store at \u003cb\u003e2–8 °C\u003c\/b\u003e on receipt; protect from heat, light and moisture, and avoid excessive agitation. If reconstitution is required for laboratory work, use sterile technique — bacteriostatic water, or 0.6% acetic acid for low-solubility peptides. Protocols vary by research application.\u003c\/p\u003e\n\u003c\/section\u003e\n\u003csection\u003e\n\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M4 5a2 2 0 0 1 2-2h13v16H6a2 2 0 0 0-2 2z\"\u003e\u003c\/path\u003e\u003cpath d=\"M19 17H6a2 2 0 0 0-2 2\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\n\u003ch3\u003eReferences\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"mvd__refs\"\u003e\n\u003cli\u003eJastreboff AM, Kaplan LM, Frías JP, et al. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. \u003cem\u003eN Engl J Med.\u003c\/em\u003e 2023;389(6):514–526. \u003ca href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2301972\" target=\"_blank\"\u003enejm.org\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eCoskun T, Urva S, Roell WC, et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept. \u003cem\u003eCell Metab.\u003c\/em\u003e 2022;34(9):1234–1247. \u003ca href=\"https:\/\/www.cell.com\/cell-metabolism\/fulltext\/S1550-4131(22)00312-6\" target=\"_blank\"\u003ecell.com\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eUrva S, Coskun T, Loh MT, et al. LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b trial. \u003cem\u003eLancet.\u003c\/em\u003e 2022;400(10366):1869–1881. \u003ca href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(22)02033-5\/abstract\" target=\"_blank\"\u003ethelancet.com\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"mvd__note\"\u003e\n\u003cstrong\u003eResearch use only.\u003c\/strong\u003e Research-grade, high-purity material (≥98.7% HPLC) supplied strictly for laboratory and analytical purposes. Not for human or animal consumption; not a drug or dietary supplement; not approved by the FDA, EMA or other agencies. To be handled only by qualified professionals in appropriate facilities, under all applicable laws. A certificate of analysis may be available on request.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MV Labs","offers":[{"title":"5mg","offer_id":45137033101427,"sku":null,"price":1500.0,"currency_code":"MXN","in_stock":true},{"title":"10mg","offer_id":45137025695859,"sku":"RT10","price":2800.0,"currency_code":"MXN","in_stock":true},{"title":"30mg","offer_id":45137033724019,"sku":null,"price":6900.0,"currency_code":"MXN","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0697\/3577\/6371\/files\/Reta_Transparency.png?v=1781471339"},{"product_id":"other-example-product-2","title":"CJC + IPA","description":"\u003cdiv style=\"font-family:Arial,sans-serif;max-width:680px;margin:20px 0 24px;border:1px solid #cbd5e1;border-radius:10px;overflow:hidden;\"\u003e\n\u003cdiv style=\"background:#1a3c5e;color:#fff;padding:12px 16px;\"\u003e\n\u003cstrong style=\"font-size:15px;\"\u003eProtocolo de Dosificación\u003c\/strong\u003e\u003cspan style=\"font-size:12px;margin-left:12px;opacity:0.85;\"\u003e2–3 veces al día · Subcutáneo\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"background:#e8f0f8;padding:10px 16px;font-size:13px;color:#1a3c5e;\"\u003e\n\u003cstrong\u003eReconstitución:\u003c\/strong\u003e 10 mg total (5 mg CJC + 5 mg IPA) + 3 mL BAC Water = 3.33 mg\/mL\u003c\/div\u003e\n\u003ctable style=\"width:100%;border-collapse:collapse;font-size:13px;\"\u003e\n\u003cthead\u003e\u003ctr style=\"background:#2d5a8e;color:#fff;\"\u003e\n\u003cth style=\"padding:8px 10px;text-align:left;\"\u003eFase\u003c\/th\u003e\n\u003cth style=\"padding:8px 10px;text-align:left;\"\u003eDosis\u003c\/th\u003e\n\u003cth style=\"padding:8px 10px;text-align:center;\"\u003eUnidades (U-100)\u003c\/th\u003e\n\u003cth style=\"padding:8px 10px;text-align:center;\"\u003eVolumen (mL)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr style=\"background:#f8fafc\"\u003e\n\u003ctd style=\"padding:8px 10px;border-bottom:1px solid #e2e8f0;\"\u003eEstándar\u003c\/td\u003e\n\u003ctd style=\"padding:8px 10px;border-bottom:1px solid #e2e8f0;font-weight:600;color:#1a3c5e;\"\u003e200 mcg CJC + 200 mcg IPA\u003c\/td\u003e\n\u003ctd style=\"padding:8px 10px;border-bottom:1px solid #e2e8f0;text-align:center;\"\u003e24 unidades\u003c\/td\u003e\n\u003ctd style=\"padding:8px 10px;border-bottom:1px solid #e2e8f0;text-align:center;\"\u003e0.24 mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background:#ffffff\"\u003e\n\u003ctd style=\"padding:8px 10px;border-bottom:1px solid #e2e8f0;\"\u003eReducida\u003c\/td\u003e\n\u003ctd style=\"padding:8px 10px;border-bottom:1px solid #e2e8f0;font-weight:600;color:#1a3c5e;\"\u003e100 mcg CJC + 100 mcg IPA\u003c\/td\u003e\n\u003ctd style=\"padding:8px 10px;border-bottom:1px solid #e2e8f0;text-align:center;\"\u003e12 unidades\u003c\/td\u003e\n\u003ctd style=\"padding:8px 10px;border-bottom:1px solid #e2e8f0;text-align:center;\"\u003e0.12 mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cdiv style=\"background:#f8fafc;padding:8px 16px;font-size:11px;color:#64748b;\"\u003e⚠️ Solo para investigación. Consulta a un profesional de salud calificado antes de uso.\u003c\/div\u003e\n\u003c\/div\u003e\u003ch2\u003eCJC-1295 + Ipamorelin Blend — Synergistic GH Research Stack\u003c\/h2\u003e\n\u003cp\u003eThis pre-blended combination of CJC-1295 (no DAC, GHRH analog) and Ipamorelin (GHRP\/ghrelin agonist) targets two complementary receptor pathways to produce maximally amplified, pulsatile growth hormone release. This is one of the most widely researched GH-optimizing stacks.\u003c\/p\u003e\n\n\u003ch3\u003eResearch Applications\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eMaximized pulsatile GH release research\u003c\/li\u003e\n\u003cli\u003eAnti-aging and longevity protocols\u003c\/li\u003e\n\u003cli\u003eMuscle anabolism and fat loss combination studies\u003c\/li\u003e\n\u003cli\u003eIGF-1 optimization and connective tissue support\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eReconstitution\u003c\/h3\u003e\n\u003cp\u003eReconstitute with 2 mL BAC water for standard concentration. Use U-100 insulin syringe for dosing.\u003c\/p\u003e\n\n\u003ch3\u003eDosing Protocol (Research Reference)\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 100 µg each component (CJC + IPA) per injection\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFrequency:\u003c\/strong\u003e 2–3× daily (AM + pre-workout\/bedtime), fasted state\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRoute:\u003c\/strong\u003e Subcutaneous injection\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCycle:\u003c\/strong\u003e 12 weeks on, 4 weeks off\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eStorage\u003c\/h3\u003e\n\u003cp\u003eStore lyophilized at −20°C. After reconstitution, refrigerate at 2–8°C and use within 21 days.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e⚠️ For research use only.\u003c\/em\u003e\u003c\/p\u003e","brand":"MV Labs","offers":[{"title":"Default Title","offer_id":44438965747827,"sku":null,"price":3200.0,"currency_code":"MXN","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0697\/3577\/6371\/files\/CJCIPATransparency_512b124f-2815-4443-960c-661556e68067.png?v=1781623197"},{"product_id":"tirzepatide","title":"Tirzepatide","description":"\u003cp\u003e \u003c\/p\u003e\n\u003cstyle\u003e\n:root{--d:#0b3347;--p:#0e4f68;--m:#2590b4;--l:#5ab4cc;--pl:#cce8f2;--ic:#e8f5fa;--t:#0a1e2c;--mu:#456d80;--r:14px}\n*{box-sizing:border-box}.pg{font-family:-apple-system,BlinkMacSystemFont,'Segoe UI',sans-serif;color:var(--t);max-width:880px;margin:0 auto;padding:0 16px 60px;line-height:1.7}\n.pg h1,.pg h2,.pg h3,.pg p,.pg ul,.pg ol,.pg li,.pg a{margin:0 0 10px;font-size:14px}\n.pg h1{font-size:clamp(20px,4vw,32px);font-weight:900;letter-spacing:-.03em;color:var(--d)}\n.pg h2{font-size:17px;font-weight:800;color:var(--d)}\n.pg h3{font-size:14px;font-weight:700;color:var(--p);margin:14px 0 5px}\n.pg a{color:var(--m);text-decoration:underline}\n.hero{background:linear-gradient(135deg,var(--d) 0%,var(--p) 65%,var(--m) 100%);border-radius:var(--r);padding:34px 26px 30px;margin-bottom:22px;color:#fff;position:relative;overflow:hidden}\n.hero::before{content:'';position:absolute;inset:0;background:url(\"data:image\/svg+xml,%3Csvg width='60' height='60' xmlns='http:\/\/www.w3.org\/2000\/svg'%3E%3Cg fill='%23ffffff' fill-opacity='0.04'%3E%3Cpolygon points='30,5 55,18 55,42 30,55 5,42 5,18'\/%3E%3C\/g%3E%3C\/svg%3E\");pointer-events:none}\n.badge{display:inline-flex;align-items:center;background:rgba(255,255,255,.15);border:1px solid rgba(255,255,255,.25);border-radius:20px;padding:3px 12px;font-size:11px;font-weight:600;letter-spacing:.06em;text-transform:uppercase;margin-bottom:11px;gap:5px}\n.hero h1{color:#fff;font-size:clamp(21px,4.5vw,34px);font-weight:900;letter-spacing:-.03em;margin:0 0 8px}\n.hero p{opacity:.88;font-size:14px;max-width:520px;margin:0 0 12px}\n.hmeta{display:flex;flew-wrap:wrap;gap:9px;font-size:11px;opacity:.75}\n.warn{background:#fffbeb;border:1.5px solid #fcd34d;border-left:5px solid #b45309;border-radius:var(--r);padding:11px 14px;margin-bottom:18px;font-size:12.5px;color:#92400e;line-height:1.6}\n.warn strong{color:#78350f}\n.stats{display:grid;grid-template-columns:repeat(auto-fit,minmax(115px,1fr));gap:8px;margin:10px 0 14px}\n.sc{background:var(--ic);border:1.5px solid var(--pl);border-radius:10px;padding:11px 9px;text-align:center}\n.sv{font-size:22px;font-weight:900;color:var(--p);line-height:1;margin-bottom:3px}\n.sl{font-size:9px;color:var(--mu);font-weight:600;text-transform:uppercase;letter-spacing:.05em}\n.ss{font-size:8.5px;color:var(--mu);margin-top:2px}\n.sec{background:#fff;border:1.5px solid var(--pl);border-radius:var(--r);margin-bottom:11px;box-shadow:0 2px 5px rgba(11,51,71,.05);overflow:hidden}\n.sec details\u003esummary{display:flex;align-items:center;justify-content:space-between;padding:14px 18px;cursor:pointer;user-select:none;list-style:none;gap:8px}\n.sec details\u003esummary::-webkit-details-marker,.sec details\u003esummary::marker{display:none}\n.shd{display:flex;align-items:center;gap:8px}\n.sic{width:30px;height:30px;border-radius:7px;flex-shrink:0;background:var(--ic);display:flex;align-items:center;justify-content:center;font-size:15px}\n.stt{font-size:13.5px;font-weight:700;color:var(--p)}.sub{font-size:10.5px;color:var(--mu);margin-top:1px}\n.sarr{width:17px;height:17px;flex-shrink:0;color:var(--m);transition:transform .25s}\ndetails[open] .sarr{transform:rotate(180deg)}\n.sbd{padding:0 18px 18px}.sdiv{height:1.5px;background:var(--pl);margin:0 18px 14px}\n.chart{background:var(--ic);border:1.5px solid var(--pl);border-radius:10px;padding:14px 11px;margin:10px o;overflow-x:auto}\n.ct{font-size:10px;font-weight:700;color:var(--mu);text-transform:uppercase;letter-spacing:.06em;margin-bottom:9px}\n.cs{font-size:9px;color:var(--mu);margin-top:5px;text-align:right}\n.tbl{width:100%;border-collapse:collapse;font-size:12px;margin:8px 0}\n.tbl th{background:var(--p);color:#fff;padding:7px 9px;text-align:left;font-size:10px;text-transform:uppercase;letter-spacing:.05em}\n.tbl th:first-child{border-radius:5px 0 0 0}.tbl th:last-child{border-radius:0 5px 0 0}\n.tbl td{padding:6px 9px;border-bottom:1px solid var(--pl);font-size:12px}\n.tbl tr:last-child td{border-bottom:none}.tbl tr:nth-child(even) td{background:var(--ic)}\n.tbl .ph{font-weight:600;color:var(--p)}.tbl .mx td{background:#e0f2fe!important;font-weight:700;color:var(--d)}\n.recon{background:linear-gradient(135deg,var(--d),var(--p));border-radius:10px;padding:14px 16px;color:#fff;margin:10px 0}\n.recon h3{color:#fff;margin-top:0;font-size:11.5px;opacity:.85;text-transform:uppercase;letter-spacing:.07em}\n.rf{font-size:17px;font-weight:800;margin:4px 0;letter-spacing:-.01em}.rd{font-size:11.5px;opacity:.8}\n.cta{background:linear-gradient(135deg,var(--p),var(--m));border-radius:var(--r);padding:18px 20px;display:flex;align-items:center;justify-content:space-between;flex-wrap:wrap;gap:10px;margin:16px 0;text-decoration:none!important}\n.cta-t{color:#fff}.cta-t strong{display:block;font-size:14px;font-weight:800;margin-bottom:2px}\n.cta-t span{font-size:12px;opacity:.85}\n.cta-b{background:#fff;color:var(--p);font-weight:800;font-size:12px;border-radius:8px;padding:7px 14px;white-space:nowrap;flex-shrink:0}\n.chip{display:inline-flex;background:var(--ic);border:1px solid var(--pl);border-radius:20px;padding:2px 8px;font-size:10px;color:var(--mu);text-decoration:none;margin:2px}\n.chip:hover{background:var(--pl);color:var(--p)}\n.fn{border-top:2px solid var(--pl);margin-top:28px;padding-top:16px}\n.fn h4{font-size:10px;text-transform:uppercase;letter-spacing:.08em;color:var(--mu);margin:0 0 9px}\n.fnl{list-style:none;padding:0;margin:0}.fnl li{font-size:10.5px;color:var(--mu);margin-bottom:5px;padding-left:18px;position:relative;line-height:1.5}\n.fnl li::before{content:attr(data-n);position:absolute;left:0;font-weight:700;color:var(--m)}\n.fnl a{color:var(--m)}\n@media(max-width:600px){.hero{padding:22px 14px 18px}.sbd{padding:0 10px 14px}.cta{flex-direction:column}.stats{grid-template-columns:repeat(2,1fr)}}\n\u003c\/style\u003e\n\u003cdiv class=\"pg\"\u003e\n\u003cdiv class=\"hero\"\u003e\n\u003cdiv class=\"badge\"\u003e🔬 Research Reference · MVLabs.mx · México · GLP-1\/GIP · Dual Agonist\u003c\/div\u003e\n\u003ch1\u003eTirzepatide\u003c\/h1\u003e\n\u003cp\u003eThe first dual GLP-1\/GIP agonist. SURMOUNT-1 Phase 3 showed up to 22.5% mean weight loss — surpassing any previous weight pharmacotherapy. Available for research in Mexico.\u003c\/p\u003e\n\u003cdiv class=\"hmeta\"\u003e\n\u003cspan\u003e📋 Research only\u003c\/span\u003e\u003cspan\u003e💊 10 mg\/vial\u003c\/span\u003e\u003cspan\u003e⏱ t½ ~5 days\u003c\/span\u003e\u003cspan\u003e🇲🇽 México\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"warn\"\u003e\n\u003cstrong\u003e⚠ Research Use Only \/ Solo Uso de Investigación.\u003c\/strong\u003e All information is for educational and scientific research only. Not approved for human use by FDA or COFEPRIS. For in-vitro and pre-clinical research only. MVLabs.mx · \u003ca href=\"\/pages\/peptide-calculator\"\u003ePeptide Calculator\u003c\/a\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"stats\"\u003e\n\u003cdiv class=\"sc\"\u003e\n\u003cdiv class=\"sv\"\u003e22.5%\u003c\/div\u003e\n\u003cdiv class=\"sl\"\u003eMax weight loss\u003c\/div\u003e\n\u003cdiv class=\"ss\"\u003eSURMOUNT-1\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sc\"\u003e\n\u003cdiv class=\"sv\"\u003e5 days\u003c\/div\u003e\n\u003cdiv class=\"sl\"\u003eHalf-life\u003c\/div\u003e\n\u003cdiv class=\"ss\"\u003eOnce weekly\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sc\"\u003e\n\u003cdiv class=\"sv\"\u003e15 mg\u003c\/div\u003e\n\u003cdiv class=\"sl\"\u003eMax dose\u003c\/div\u003e\n\u003cdiv class=\"ss\"\u003eWeekly SC\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sc\"\u003e\n\u003cdiv class=\"sv\"\u003e2,539\u003c\/div\u003e\n\u003cdiv class=\"sl\"\u003ePhase 3 N\u003c\/div\u003e\n\u003cdiv class=\"ss\"\u003eSURMOUNT-1\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sec\"\u003e\n\u003cdetails open=\"\"\u003e\n\u003csummary\u003e🧬Mechanism of ActionGLP-1\/GIP Dual Agonist · SURMOUNT Trials\u003csvg class=\"sarr\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"\u003e\u003cpath d=\"m6 9 6 6 6-6\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003c\/summary\u003e\n\u003cdiv class=\"sdiv\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv class=\"sbd\"\u003e\n\u003cp\u003eTirzepatide is a 39-aa peptide with balanced agonism at GLP-1R and GIPR. GIP co-agonism potentiates GLP-1-mediated satiety while reducing nausea, enabling dose escalation to levels not tolerable with GLP-1 alone. Dual mechanism enhances appetite reduction, insulin sensitivity, and adipose remodeling.\u003csup class=\"fn\"\u003e[1]\u003c\/sup\u003e\u003c\/p\u003e\n\u003cdiv style=\"display: flex; gap: 5px; flex-wrap: wrap; margin-top: 6px;\"\u003e\u003ca class=\"chip\" href=\"\/pages\/peptide-calculator\"\u003e🧮 Peptide Calculator\u003c\/a\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sec\"\u003e\n\u003cdetails\u003e\n\u003csummary\u003e📊Clinical EvidencePublished research data\u003csvg class=\"sarr\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"\u003e\u003cpath d=\"m6 9 6 6 6-6\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003c\/summary\u003e\n\u003cdiv class=\"sdiv\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv class=\"sbd\"\u003e\n\u003cp\u003eSURMOUNT-1 (Jastreboff et al., NEJM 2022): N=2,539, 72 weeks.\u003csup class=\"fn\"\u003e[1]\u003c\/sup\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e15 mg\/week: −22.5% mean weight loss\u003c\/li\u003e\n\u003cli\u003e10 mg: −19.5% · 5 mg: −15.0%\u003c\/li\u003e\n\u003cli\u003eFDA approved as Zepbound® (Nov 2023)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv style=\"display: flex; gap: 5px; flex-wrap: wrap;\"\u003e\u003ca class=\"chip\" href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2206038\" target=\"_blank\"\u003e📄 SURMOUNT-1 NEJM\u003c\/a\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sec\"\u003e\n\u003cdetails\u003e\n\u003csummary\u003e📋Research Dosing Protocol⚠ Research reference only — not medical advice\u003csvg class=\"sarr\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"\u003e\u003cpath d=\"m6 9 6 6 6-6\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003c\/summary\u003e\n\u003cdiv class=\"sdiv\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv class=\"sbd\"\u003e\n\u003cdiv class=\"recon\"\u003e\n\u003ch3\u003eReconstitution\u003c\/h3\u003e\n\u003cdiv class=\"rf\"\u003e10 mg + 2 mL BAC Water = 5 mg\/mL\u003c\/div\u003e\n\u003cdiv class=\"rd\"\u003e1 U-100 = 50 µg · Store 2–8°C · Use within 28 days\u003c\/div\u003e\n\u003c\/div\u003e\n\u003ctable class=\"tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003ePhase\u003c\/th\u003e\n\u003cth\u003eDose\u003c\/th\u003e\n\u003cth\u003eUnits (U-100)\u003c\/th\u003e\n\u003cth\u003eVolume\u003c\/th\u003e\n\u003cth\u003eNotes\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd class=\"ph\"\u003eWeeks 1–4\u003c\/td\u003e\n\u003ctd\u003e2.5 mg\u003c\/td\u003e\n\u003ctd\u003e50 U\u003c\/td\u003e\n\u003ctd\u003e0.50 mL\u003c\/td\u003e\n\u003ctd\u003eStarting\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"ph\"\u003eWeeks 5–8\u003c\/td\u003e\n\u003ctd\u003e5 mg\u003c\/td\u003e\n\u003ctd\u003e100 U\u003c\/td\u003e\n\u003ctd\u003e1.00 mL\u003c\/td\u003e\n\u003ctd\u003ePer tolerance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"ph\"\u003eWeeks 9–12\u003c\/td\u003e\n\u003ctd\u003e7.5 mg\u003c\/td\u003e\n\u003ctd\u003e150 U*\u003c\/td\u003e\n\u003ctd\u003e1.50 mL*\u003c\/td\u003e\n\u003ctd\u003ePer tolerance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"ph\"\u003eWeeks 13–16\u003c\/td\u003e\n\u003ctd\u003e10 mg\u003c\/td\u003e\n\u003ctd\u003e200 U*\u003c\/td\u003e\n\u003ctd\u003e2.00 mL*\u003c\/td\u003e\n\u003ctd\u003ePer tolerance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"mx\"\u003e\n\u003ctd class=\"ph\"\u003eWeeks 17+\u003c\/td\u003e\n\u003ctd\u003e15 mg\u003c\/td\u003e\n\u003ctd\u003e300 U*\u003c\/td\u003e\n\u003ctd\u003e3.00 mL*\u003c\/td\u003e\n\u003ctd\u003eMax · *use 3mL syringe\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ca class=\"cta\" href=\"\/pages\/peptide-calculator\"\u003e\n\u003cdiv class=\"cta-t\"\u003e\n\u003cstrong\u003e🧮 MVLabs.mx Peptide Calculator\u003c\/strong\u003e\u003cspan\u003eCalculate exact units \u0026amp; volumes — syringe slider included\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"cta-b\"\u003eOpen Calculator →\u003c\/div\u003e\n\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sec\"\u003e\n\u003cdetails\u003e\n\u003csummary\u003e⚠️Safety ProfileAdverse event reference\u003csvg class=\"sarr\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"\u003e\u003cpath d=\"m6 9 6 6 6-6\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003c\/summary\u003e\n\u003cdiv class=\"sdiv\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv class=\"sbd\"\u003e\n\u003cul\u003e\n\u003cli\u003eNausea (~31%), diarrhea (~23%) — milder than semaglutide due to GIP co-agonism\u003c\/li\u003e\n\u003cli\u003eDiscontinuation: 4.3% at 15mg\u003c\/li\u003e\n\u003cli\u003ePancreatitis: rare; monitor\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fn\"\u003e\n\u003ch4\u003eReferences\u003c\/h4\u003e\n\u003col class=\"fnl\"\u003e\n\u003cli data-n=\"[1]\"\u003eJastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205–216. \u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2206038\"\u003eDOI\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp style=\"font-size: 10px; color: var(--mu); margin-top: 10px;\"\u003e© 2026 MVLabs.mx · Tirzepatide México · Zepbound México investigación · GLP-1 GIP México · \u003ca href=\"\/pages\/peptide-calculator\"\u003ePeptide Calculator\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MV Labs","offers":[{"title":"Default Title","offer_id":44444429320307,"sku":null,"price":2100.0,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0697\/3577\/6371\/files\/TirzepatideTransparency.png?v=1782765378"},{"product_id":"semaglutide","title":"Semaglutide","description":"\u003cstyle\u003e.mvd{font-family:Satoshi,system-ui,sans-serif;color:#13242a;line-height:1.62;font-size:15px}.mvd *{box-sizing:border-box}.mvd__chips{display:flex;flex-wrap:wrap;gap:8px;margin:0 0 22px}.mvd__chip{display:inline-flex;align-items:center;gap:7px;background:#e7f1f3;color:#0B6675;font-family:\"JetBrains Mono\",monospace;font-size:12px;font-weight:500;padding:7px 12px;border-radius:100px}.mvd__chip b{color:#0E8294}.mvd__chip--ruo{background:#13242a;color:#cfe8ec}.mvd__hero{display:flex;gap:16px;align-items:center;background:linear-gradient(120deg,#f4fafb,#eaf3f4);border:1px solid #d8e6e8;border-radius:16px;padding:16px 20px;margin:0 0 24px}.mvd__hero svg{flex:0 0 auto}.mvd__hero p{margin:0;font-size:14.5px;color:#3a4f56}.mvd section{margin:0 0 20px}.mvd__h{display:flex;align-items:center;gap:9px;margin:0 0 9px}.mvd__h svg{flex:0 0 auto;color:#0E8294}.mvd__h h3{font-family:\"Cabinet Grotesk\",sans-serif;font-weight:800;font-size:17px;margin:0;letter-spacing:-.01em}.mvd ul{margin:6px 0 0;padding:0;list-style:none;display:grid;gap:7px}.mvd ul li{position:relative;padding-left:20px;font-size:14.5px;color:#33474e}.mvd ul li::before{content:\"\";position:absolute;left:2px;top:8px;width:7px;height:7px;border-radius:50%;background:#15a0b4}.mvd p{margin:0 0 10px}.mvd__btn{display:inline-flex;align-items:center;gap:8px;background:#0E8294;color:#fff;font-weight:700;text-decoration:none;padding:11px 18px;border-radius:100px;font-size:14px;margin-top:4px}.mvd__note{background:#fbfcfd;border:1px solid #e3e9ec;border-radius:14px;padding:16px 18px;font-size:13.5px;color:#51646B}.mvd__note strong{color:#13242a}@media(max-width:520px){.mvd__hero{flex-direction:column;text-align:center}}.mvd__cmp{display:grid;gap:11px;margin:4px 0 12px}.mvd__cmprow{display:grid;grid-template-columns:135px 1fr 52px;align-items:center;gap:12px}.mvd__cmpname{font-size:13px;font-weight:700;color:#13242a}.mvd__cmpname small{display:block;font-weight:500;color:#7c8a90;font-size:10.5px;font-family:\"JetBrains Mono\",monospace}.mvd__cmptrack{height:13px;border-radius:100px;background:#e7f1f3;overflow:hidden}.mvd__cmpfill{height:100%;border-radius:100px;background:linear-gradient(90deg,#0E8294,#15a0b4)}.mvd__cmprow--muted .mvd__cmpfill{background:#aac9d0}.mvd__cmpval{font-family:\"JetBrains Mono\",monospace;font-weight:500;font-size:13px;color:#0B6675;text-align:right}.mvd__src{font-size:11.5px;color:#809096;margin-top:-2px}\u003c\/style\u003e\u003cdiv class=\"mvd\"\u003e\n\u003cdiv class=\"mvd__chips\"\u003e\n\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003ePurity\u003c\/b\u003e ≥98.7% HPLC\u003c\/span\u003e\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003eFormat\u003c\/b\u003e Lyophilized powder\u003c\/span\u003e\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003e10 mg \/ vial\u003c\/b\u003e\u003c\/span\u003e\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003eSKU\u003c\/b\u003e SM10\u003c\/span\u003e\u003cspan class=\"mvd__chip mvd__chip--ruo\"\u003eResearch use only\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"mvd__hero\"\u003e\n\u003csvg width=\"90\" height=\"62\" viewbox=\"0 0 90 62\" fill=\"none\"\u003e\u003ccircle cx=\"15\" cy=\"14\" r=\"9\" fill=\"#0E8294\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"15\" cy=\"48\" r=\"9\" fill=\"#15a0b4\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"44\" cy=\"31\" r=\"10\" fill=\"#0B6675\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"74\" cy=\"31\" r=\"8\" fill=\"none\" stroke=\"#0E8294\" stroke-width=\"2.4\" stroke-dasharray=\"3 3\"\u003e\u003c\/circle\u003e\u003cpath d=\"M24 17 35 28M24 45 35 34M54 31H66\" stroke=\"#9cc6cd\" stroke-width=\"2\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003cp\u003eStudied across metabolic and energy-balance pathways.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003ccircle cx=\"12\" cy=\"12\" r=\"9\"\u003e\u003c\/circle\u003e\u003cpath d=\"M12 7v10M7 12h10\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSemaglutide is a GLP-1 receptor agonist peptide widely studied in metabolic and endocrine research. It is a synthetic analog of native glucagon-like peptide-1 with strategically placed amino acid substitutions and a C-18 fatty acid chain that enables albumin binding, dramatically extending its plasma half-life to approximately 7 days.\u003c\/p\u003e \u003cp\u003eAs an agonist at the GLP-1 receptor, semaglutide stimulates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and modulates appetite signaling centers in the hypothalamus. It is approved as a pharmaceutical in multiple countries but supplied here as research-grade material for laboratory use only.\u003c\/p\u003e\u003c\/section\u003e\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M9 3v6l-5 9a2 2 0 0 0 2 3h12a2 2 0 0 0 2-3l-5-9V3\"\u003e\u003c\/path\u003e\u003cpath d=\"M8 3h8\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eResearch applications\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003eGLP-1 receptor pharmacology and downstream signaling\u003c\/li\u003e\n\u003cli\u003eGlucose homeostasis and insulin secretion studies\u003c\/li\u003e\n\u003cli\u003eAppetite and satiety modulation research\u003c\/li\u003e\n\u003cli\u003eGastric emptying and gastrointestinal motility research\u003c\/li\u003e\n\u003cli\u003eCardiovascular risk factor research in metabolic disease models\u003c\/li\u003e\n\u003cli\u003eComparison with other GLP-1 analogs (liraglutide, dulaglutide, etc.)\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/section\u003e\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M12 2v6M12 8 7 18a2 2 0 0 0 2 3h6a2 2 0 0 0 2-3z\"\u003e\u003c\/path\u003e\u003cpath d=\"M8.5 14h7\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eHandling \u0026amp; storage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSupplied as a lyophilized powder. Store at \u003cb\u003e2–8 °C\u003c\/b\u003e on receipt; protect from heat, light and moisture, and avoid excessive agitation. If reconstitution is required for laboratory work, use sterile technique — bacteriostatic water, or 0.6% acetic acid for low-solubility peptides. Protocols vary by research application.\u003c\/p\u003e\n\u003ca class=\"mvd__btn\" href=\"https:\/\/mvlabs.mx\/pages\/calculadora-de-peptidos\" target=\"_blank\"\u003eUse the peptide calculator →\u003c\/a\u003e\u003c\/section\u003e\u003cdiv class=\"mvd__note\"\u003e\n\u003cstrong\u003eResearch use only.\u003c\/strong\u003e Research-grade, high-purity material (≥98.7% HPLC) supplied strictly for laboratory and analytical purposes. Not for human or animal consumption; not a drug or dietary supplement; not approved by the FDA, EMA or other agencies. To be handled only by qualified professionals in appropriate facilities, under all applicable laws. A certificate of analysis may be available on request.\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MV Labs","offers":[{"title":"10 mg","offer_id":44510488625267,"sku":"SM10","price":1500.0,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0697\/3577\/6371\/files\/SemaglutideTransparency.png?v=1782425589"},{"product_id":"cagrilintide","title":"Cagrilintide","description":"\u003cstyle\u003e.mvd{font-family:Satoshi,system-ui,sans-serif;color:#13242a;line-height:1.62;font-size:15px}.mvd *{box-sizing:border-box}.mvd__chips{display:flex;flex-wrap:wrap;gap:8px;margin:0 0 22px}.mvd__chip{display:inline-flex;align-items:center;gap:7px;background:#e7f1f3;color:#0B6675;font-family:\"JetBrains Mono\",monospace;font-size:12px;font-weight:500;padding:7px 12px;border-radius:100px}.mvd__chip b{color:#0E8294}.mvd__chip--ruo{background:#13242a;color:#cfe8ec}.mvd__hero{display:flex;gap:16px;align-items:center;background:linear-gradient(120deg,#f4fafb,#eaf3f4);border:1px solid #d8e6e8;border-radius:16px;padding:16px 20px;margin:0 0 24px}.mvd__hero svg{flex:0 0 auto}.mvd__hero p{margin:0;font-size:14.5px;color:#3a4f56}.mvd section{margin:0 0 20px}.mvd__h{display:flex;align-items:center;gap:9px;margin:0 0 9px}.mvd__h svg{flex:0 0 auto;color:#0E8294}.mvd__h h3{font-family:\"Cabinet Grotesk\",sans-serif;font-weight:800;font-size:17px;margin:0;letter-spacing:-.01em}.mvd ul{margin:6px 0 0;padding:0;list-style:none;display:grid;gap:7px}.mvd ul li{position:relative;padding-left:20px;font-size:14.5px;color:#33474e}.mvd ul li::before{content:\"\";position:absolute;left:2px;top:8px;width:7px;height:7px;border-radius:50%;background:#15a0b4}.mvd p{margin:0 0 10px}.mvd__btn{display:inline-flex;align-items:center;gap:8px;background:#0E8294;color:#fff;font-weight:700;text-decoration:none;padding:11px 18px;border-radius:100px;font-size:14px;margin-top:4px}.mvd__note{background:#fbfcfd;border:1px solid #e3e9ec;border-radius:14px;padding:16px 18px;font-size:13.5px;color:#51646B}.mvd__note strong{color:#13242a}@media(max-width:520px){.mvd__hero{flex-direction:column;text-align:center}}.mvd__cmp{display:grid;gap:11px;margin:4px 0 12px}.mvd__cmprow{display:grid;grid-template-columns:135px 1fr 52px;align-items:center;gap:12px}.mvd__cmpname{font-size:13px;font-weight:700;color:#13242a}.mvd__cmpname small{display:block;font-weight:500;color:#7c8a90;font-size:10.5px;font-family:\"JetBrains Mono\",monospace}.mvd__cmptrack{height:13px;border-radius:100px;background:#e7f1f3;overflow:hidden}.mvd__cmpfill{height:100%;border-radius:100px;background:linear-gradient(90deg,#0E8294,#15a0b4)}.mvd__cmprow--muted .mvd__cmpfill{background:#aac9d0}.mvd__cmpval{font-family:\"JetBrains Mono\",monospace;font-weight:500;font-size:13px;color:#0B6675;text-align:right}.mvd__src{font-size:11.5px;color:#809096;margin-top:-2px}\u003c\/style\u003e\u003cdiv class=\"mvd\"\u003e\n\u003cdiv class=\"mvd__chips\"\u003e\n\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003ePurity\u003c\/b\u003e ≥98.7% HPLC\u003c\/span\u003e\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003eFormat\u003c\/b\u003e Lyophilized powder\u003c\/span\u003e\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003e10 mg \/ vial\u003c\/b\u003e\u003c\/span\u003e\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003eSKU\u003c\/b\u003e CGL10\u003c\/span\u003e\u003cspan class=\"mvd__chip mvd__chip--ruo\"\u003eResearch use only\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"mvd__hero\"\u003e\n\u003csvg width=\"90\" height=\"62\" viewbox=\"0 0 90 62\" fill=\"none\"\u003e\u003ccircle cx=\"15\" cy=\"14\" r=\"9\" fill=\"#0E8294\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"15\" cy=\"48\" r=\"9\" fill=\"#15a0b4\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"44\" cy=\"31\" r=\"10\" fill=\"#0B6675\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"74\" cy=\"31\" r=\"8\" fill=\"none\" stroke=\"#0E8294\" stroke-width=\"2.4\" stroke-dasharray=\"3 3\"\u003e\u003c\/circle\u003e\u003cpath d=\"M24 17 35 28M24 45 35 34M54 31H66\" stroke=\"#9cc6cd\" stroke-width=\"2\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003cp\u003eStudied across metabolic and energy-balance pathways.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003ccircle cx=\"12\" cy=\"12\" r=\"9\"\u003e\u003c\/circle\u003e\u003cpath d=\"M12 7v10M7 12h10\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCagrilintide is a long-acting amylin analog peptide under clinical investigation for metabolic research. It is designed to act on amylin receptors — heteroreceptor complexes of the calcitonin receptor (CALCR) with receptor activity-modifying proteins (RAMP1, RAMP2, RAMP3) — which are expressed in the area postrema, nucleus tractus solitarius, and hypothalamus.\u003c\/p\u003e \u003cp\u003eBy activating these receptors, cagrilintide modulates satiety, slows gastric emptying, and suppresses glucagon secretion. It is frequently studied in combination with GLP-1 receptor agonists such as semaglutide, representing a complementary dual-mechanism approach to metabolic regulation research.\u003c\/p\u003e\u003c\/section\u003e\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M9 3v6l-5 9a2 2 0 0 0 2 3h12a2 2 0 0 0 2-3l-5-9V3\"\u003e\u003c\/path\u003e\u003cpath d=\"M8 3h8\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eResearch applications\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003eAmylin receptor (CALCR\/RAMP complex) pharmacology\u003c\/li\u003e\n\u003cli\u003eSatiety signaling and gastric emptying modulation studies\u003c\/li\u003e\n\u003cli\u003eGlucagon suppression and glucose homeostasis research\u003c\/li\u003e\n\u003cli\u003eCombination protocols with GLP-1 receptor agonists\u003c\/li\u003e\n\u003cli\u003eObesity and type 2 diabetes dual-agonist research models\u003c\/li\u003e\n\u003cli\u003ePharmacokinetic studies of long-acting amylin analogs\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/section\u003e\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M12 2v6M12 8 7 18a2 2 0 0 0 2 3h6a2 2 0 0 0 2-3z\"\u003e\u003c\/path\u003e\u003cpath d=\"M8.5 14h7\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eHandling \u0026amp; storage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSupplied as a lyophilized powder. Store at \u003cb\u003e2–8 °C\u003c\/b\u003e on receipt; protect from heat, light and moisture, and avoid excessive agitation. If reconstitution is required for laboratory work, use sterile technique — bacteriostatic water, or 0.6% acetic acid for low-solubility peptides. Protocols vary by research application.\u003c\/p\u003e\n\u003ca class=\"mvd__btn\" href=\"https:\/\/mvlabs.mx\/pages\/calculadora-de-peptidos\" target=\"_blank\"\u003eUse the peptide calculator →\u003c\/a\u003e\u003c\/section\u003e\u003cdiv class=\"mvd__note\"\u003e\n\u003cstrong\u003eResearch use only.\u003c\/strong\u003e Research-grade, high-purity material (≥98.7% HPLC) supplied strictly for laboratory and analytical purposes. Not for human or animal consumption; not a drug or dietary supplement; not approved by the FDA, EMA or other agencies. To be handled only by qualified professionals in appropriate facilities, under all applicable laws. A certificate of analysis may be available on request.\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MV Labs","offers":[{"title":"10 mg","offer_id":44510488658035,"sku":"CGL10","price":4450.0,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0697\/3577\/6371\/files\/CagriTransparency.png?v=1782386075"},{"product_id":"sema-plus-cagri-blend","title":"Sema + Cagri Blend","description":"\u003cstyle\u003e.mvd{font-family:Satoshi,system-ui,sans-serif;color:#13242a;line-height:1.62;font-size:15px}.mvd *{box-sizing:border-box}.mvd__chips{display:flex;flex-wrap:wrap;gap:8px;margin:0 0 22px}.mvd__chip{display:inline-flex;align-items:center;gap:7px;background:#e7f1f3;color:#0B6675;font-family:\"JetBrains Mono\",monospace;font-size:12px;font-weight:500;padding:7px 12px;border-radius:100px}.mvd__chip b{color:#0E8294}.mvd__chip--ruo{background:#13242a;color:#cfe8ec}.mvd__hero{display:flex;gap:16px;align-items:center;background:linear-gradient(120deg,#f4fafb,#eaf3f4);border:1px solid #d8e6e8;border-radius:16px;padding:16px 20px;margin:0 0 24px}.mvd__hero svg{flex:0 0 auto}.mvd__hero p{margin:0;font-size:14.5px;color:#3a4f56}.mvd section{margin:0 0 20px}.mvd__h{display:flex;align-items:center;gap:9px;margin:0 0 9px}.mvd__h svg{flex:0 0 auto;color:#0E8294}.mvd__h h3{font-family:\"Cabinet Grotesk\",sans-serif;font-weight:800;font-size:17px;margin:0;letter-spacing:-.01em}.mvd ul{margin:6px 0 0;padding:0;list-style:none;display:grid;gap:7px}.mvd ul li{position:relative;padding-left:20px;font-size:14.5px;color:#33474e}.mvd ul li::before{content:\"\";position:absolute;left:2px;top:8px;width:7px;height:7px;border-radius:50%;background:#15a0b4}.mvd p{margin:0 0 10px}.mvd__btn{display:inline-flex;align-items:center;gap:8px;background:#0E8294;color:#fff;font-weight:700;text-decoration:none;padding:11px 18px;border-radius:100px;font-size:14px;margin-top:4px}.mvd__note{background:#fbfcfd;border:1px solid #e3e9ec;border-radius:14px;padding:16px 18px;font-size:13.5px;color:#51646B}.mvd__note strong{color:#13242a}@media(max-width:520px){.mvd__hero{flex-direction:column;text-align:center}}.mvd__cmp{display:grid;gap:11px;margin:4px 0 12px}.mvd__cmprow{display:grid;grid-template-columns:135px 1fr 52px;align-items:center;gap:12px}.mvd__cmpname{font-size:13px;font-weight:700;color:#13242a}.mvd__cmpname small{display:block;font-weight:500;color:#7c8a90;font-size:10.5px;font-family:\"JetBrains Mono\",monospace}.mvd__cmptrack{height:13px;border-radius:100px;background:#e7f1f3;overflow:hidden}.mvd__cmpfill{height:100%;border-radius:100px;background:linear-gradient(90deg,#0E8294,#15a0b4)}.mvd__cmprow--muted .mvd__cmpfill{background:#aac9d0}.mvd__cmpval{font-family:\"JetBrains Mono\",monospace;font-weight:500;font-size:13px;color:#0B6675;text-align:right}.mvd__src{font-size:11.5px;color:#809096;margin-top:-2px}\u003c\/style\u003e\u003cdiv class=\"mvd\"\u003e\n\u003cdiv class=\"mvd__chips\"\u003e\n\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003ePurity\u003c\/b\u003e ≥98.7% HPLC\u003c\/span\u003e\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003eFormat\u003c\/b\u003e Lyophilized powder\u003c\/span\u003e\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003e10 mg \/ vial (5 mg each)\u003c\/b\u003e\u003c\/span\u003e\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003eSKU\u003c\/b\u003e CS10\u003c\/span\u003e\u003cspan class=\"mvd__chip mvd__chip--ruo\"\u003eResearch use only\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"mvd__hero\"\u003e\n\u003csvg width=\"90\" height=\"62\" viewbox=\"0 0 90 62\" fill=\"none\"\u003e\u003ccircle cx=\"15\" cy=\"14\" r=\"9\" fill=\"#0E8294\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"15\" cy=\"48\" r=\"9\" fill=\"#15a0b4\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"44\" cy=\"31\" r=\"10\" fill=\"#0B6675\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"74\" cy=\"31\" r=\"8\" fill=\"none\" stroke=\"#0E8294\" stroke-width=\"2.4\" stroke-dasharray=\"3 3\"\u003e\u003c\/circle\u003e\u003cpath d=\"M24 17 35 28M24 45 35 34M54 31H66\" stroke=\"#9cc6cd\" stroke-width=\"2\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003cp\u003eStudied across metabolic and energy-balance pathways.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003ccircle cx=\"12\" cy=\"12\" r=\"9\"\u003e\u003c\/circle\u003e\u003cpath d=\"M12 7v10M7 12h10\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe Sema + Cagri Blend combines Semaglutide (GLP-1 receptor agonist, 5 mg) and Cagrilintide (amylin analog, 5 mg) in a single lyophilized co-formulation. This combination addresses two distinct and complementary pathways in metabolic regulation: the incretin pathway via GLP-1R and the amylin pathway via CALCR\/RAMP receptors.\u003c\/p\u003e \u003cp\u003eClinical research on this combination (known commercially as CagriSema) has shown additive or potentially synergistic effects on weight reduction and glycemic control compared to either agent alone, making it a subject of active investigation in obesity and metabolic syndrome research.\u003c\/p\u003e\u003c\/section\u003e\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M9 3v6l-5 9a2 2 0 0 0 2 3h12a2 2 0 0 0 2-3l-5-9V3\"\u003e\u003c\/path\u003e\u003cpath d=\"M8 3h8\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eResearch applications\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003eDual GLP-1 and amylin receptor pathway co-activation studies\u003c\/li\u003e\n\u003cli\u003eSynergistic vs additive metabolic effect research\u003c\/li\u003e\n\u003cli\u003eEnergy balance and satiety combined signaling studies\u003c\/li\u003e\n\u003cli\u003ePreclinical and clinical metabolic combination protocol models\u003c\/li\u003e\n\u003cli\u003eComparative efficacy studies: dual vs single agonist protocols\u003c\/li\u003e\n\u003cli\u003eBody weight regulation multi-target pharmacology\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/section\u003e\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M12 2v6M12 8 7 18a2 2 0 0 0 2 3h6a2 2 0 0 0 2-3z\"\u003e\u003c\/path\u003e\u003cpath d=\"M8.5 14h7\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eHandling \u0026amp; storage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSupplied as a lyophilized powder. Store at \u003cb\u003e2–8 °C\u003c\/b\u003e on receipt; protect from heat, light and moisture, and avoid excessive agitation. If reconstitution is required for laboratory work, use sterile technique — bacteriostatic water, or 0.6% acetic acid for low-solubility peptides. Protocols vary by research application.\u003c\/p\u003e\n\u003ca class=\"mvd__btn\" href=\"https:\/\/mvlabs.mx\/pages\/calculadora-de-peptidos\" target=\"_blank\"\u003eUse the peptide calculator →\u003c\/a\u003e\u003c\/section\u003e\u003cdiv class=\"mvd__note\"\u003e\n\u003cstrong\u003eResearch use only.\u003c\/strong\u003e Research-grade, high-purity material (≥98.7% HPLC) supplied strictly for laboratory and analytical purposes. Not for human or animal consumption; not a drug or dietary supplement; not approved by the FDA, EMA or other agencies. To be handled only by qualified professionals in appropriate facilities, under all applicable laws. A certificate of analysis may be available on request.\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MV Labs","offers":[{"title":"10 mg","offer_id":44510488690803,"sku":"CS10","price":3750.0,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0697\/3577\/6371\/files\/Sema_cagri_detail.png?v=1775056900"},{"product_id":"cjc-1295-with-dac","title":"CJC-1295 with DAC","description":"\u003cstyle\u003e.mvd{font-family:Satoshi,system-ui,sans-serif;color:#13242a;line-height:1.62;font-size:15px}.mvd *{box-sizing:border-box}.mvd__chips{display:flex;flex-wrap:wrap;gap:8px;margin:0 0 22px}.mvd__chip{display:inline-flex;align-items:center;gap:7px;background:rgba(255,255,255,.05);border:1px solid rgba(255,255,255,.5);color:#0B6675;font-family:\"JetBrains Mono\",monospace;font-size:12px;font-weight:500;padding:7px 12px;border-radius:100px}.mvd__chip b{color:#0E8294}.mvd__chip--ruo{background:#13242a;color:#cfe8ec}.mvd__hero{display:flex;gap:16px;align-items:center;background:linear-gradient(120deg,rgba(255,255,255,.05),rgba(255,255,255,.02));border:1px solid rgba(255,255,255,.5);border-radius:16px;padding:16px 20px;margin:0 0 24px}.mvd__hero svg{flex:0 0 auto}.mvd__hero p{margin:0;font-size:14.5px;color:#3a4f56}.mvd section{margin:0 0 20px}.mvd__h{display:flex;align-items:center;gap:9px;margin:0 0 9px}.mvd__h svg{flex:0 0 auto;color:#0E8294}.mvd__h h3{font-family:\"Cabinet Grotesk\",sans-serif;font-weight:800;font-size:17px;margin:0;letter-spacing:-.01em}.mvd ul{margin:6px 0 0;padding:0;list-style:none;display:grid;gap:7px}.mvd ul li{position:relative;padding-left:20px;font-size:14.5px;color:#33474e}.mvd ul li::before{content:\"\";position:absolute;left:2px;top:8px;width:7px;height:7px;border-radius:50%;background:#15a0b4}.mvd p{margin:0 0 10px}.mvd__btn{display:inline-flex;align-items:center;gap:8px;background:#0E8294;color:#fff;font-weight:700;text-decoration:none;padding:11px 18px;border-radius:100px;font-size:14px;margin-top:4px}.mvd__note{background:rgba(255,255,255,.04);border:1px solid rgba(255,255,255,.45);border-radius:14px;padding:16px 18px;font-size:13.5px;color:#51646B}.mvd__note strong{color:#13242a}@media(max-width:520px){.mvd__hero{flex-direction:column;text-align:center}}.mvd__cmp{display:grid;gap:11px;margin:4px 0 12px}.mvd__cmprow{display:grid;grid-template-columns:135px 1fr 52px;align-items:center;gap:12px}.mvd__cmpname{font-size:13px;font-weight:700;color:#13242a}.mvd__cmpname small{display:block;font-weight:500;color:#7c8a90;font-size:10.5px;font-family:\"JetBrains Mono\",monospace}.mvd__cmptrack{height:13px;border-radius:100px;background:rgba(255,255,255,.14);overflow:hidden}.mvd__cmpfill{height:100%;border-radius:100px;background:linear-gradient(90deg,#0E8294,#15a0b4)}.mvd__cmprow--muted .mvd__cmpfill{background:#aac9d0}.mvd__cmpval{font-family:\"JetBrains Mono\",monospace;font-weight:500;font-size:13px;color:#0B6675;text-align:right}.mvd__src{font-size:11.5px;color:#809096;margin-top:-2px}.mvd__proto{display:grid;grid-template-columns:repeat(3,1fr);gap:10px;margin:2px 0 14px}.mvd__proto div{background:rgba(255,255,255,.06);border:1px solid rgba(255,255,255,.5);border-radius:13px;padding:12px 14px}.mvd__proto span{display:block;font-family:\"JetBrains Mono\",monospace;font-size:10.5px;letter-spacing:.06em;text-transform:uppercase;color:#7c8f95;margin-bottom:6px}.mvd__proto b{font-family:\"Cabinet Grotesk\",sans-serif;font-weight:800;font-size:14.5px;color:#0B6675}.mvd__pnote{background:rgba(255,255,255,.05);border:1px solid rgba(255,255,255,.45);border-radius:13px;padding:12px 15px;font-size:13.5px;color:#51646B;margin:0 0 14px}.mvd__ptbl{width:100%;border-collapse:collapse;margin:2px 0 10px;font-size:13.5px}.mvd__ptbl th{text-align:left;font-family:\"JetBrains Mono\",monospace;font-size:10.5px;letter-spacing:.04em;text-transform:uppercase;color:#0E8294;font-weight:600;padding:8px 10px;border-bottom:1px solid rgba(255,255,255,.5)}.mvd__ptbl td{padding:9px 10px;border-bottom:1px solid rgba(255,255,255,.3);color:#33474e}.mvd__ptbl td b{color:#13242a}.mvd__ptbl tr:last-child td{border-bottom:0}@media(max-width:520px){.mvd__proto{grid-template-columns:1fr}}\u003c\/style\u003e\u003cdiv class=\"mvd\"\u003e\n\u003cdiv class=\"mvd__chips\"\u003e\n\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003ePurity\u003c\/b\u003e ≥98.7% HPLC\u003c\/span\u003e\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003eFormat\u003c\/b\u003e Lyophilized powder\u003c\/span\u003e\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003e5 mg \/ vial\u003c\/b\u003e\u003c\/span\u003e\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003eSKU\u003c\/b\u003e CD5\u003c\/span\u003e\u003cspan class=\"mvd__chip mvd__chip--ruo\"\u003eResearch use only\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"mvd__hero\"\u003e\n\u003csvg width=\"74\" height=\"62\" viewbox=\"0 0 74 62\" fill=\"none\"\u003e\u003crect x=\"10\" y=\"40\" width=\"11\" height=\"14\" rx=\"2\" fill=\"#9cc6cd\"\u003e\u003c\/rect\u003e\u003crect x=\"28\" y=\"28\" width=\"11\" height=\"26\" rx=\"2\" fill=\"#15a0b4\"\u003e\u003c\/rect\u003e\u003crect x=\"46\" y=\"14\" width=\"11\" height=\"40\" rx=\"2\" fill=\"#0E8294\"\u003e\u003c\/rect\u003e\u003cpath d=\"M12 18 36 10 64 4\" stroke=\"#0B6675\" stroke-width=\"2.4\" fill=\"none\"\u003e\u003c\/path\u003e\u003cpath d=\"M58 3l7 1-2 7\" stroke=\"#0B6675\" stroke-width=\"2.4\" fill=\"none\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003cp\u003eStudied in the growth-hormone \/ GH–IGF-1 axis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003ccircle cx=\"12\" cy=\"12\" r=\"9\"\u003e\u003c\/circle\u003e\u003cpath d=\"M12 7v10M7 12h10\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCJC-1295 with DAC (Drug Affinity Complex) is a modified analog of GHRH (growth hormone-releasing hormone) featuring a maleimidoproprionic acid (MPA) side chain that enables covalent binding to endogenous albumin through a Michael addition reaction. This albumin binding dramatically extends the compound's plasma half-life to approximately 7–10 days, enabling weekly dosing protocols in research settings.\u003c\/p\u003e \u003cp\u003eBy continuously stimulating pituitary GHRH receptors over an extended period, CJC-1295 DAC produces sustained elevations in GH and IGF-1 levels. It is studied as a model compound for long-acting GHRH receptor agonism and is often compared with shorter-acting GHRH analogs to evaluate the pharmacological consequences of continuous vs pulsatile GH stimulation.\u003c\/p\u003e\u003c\/section\u003e\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M9 3v6l-5 9a2 2 0 0 0 2 3h12a2 2 0 0 0 2-3l-5-9V3\"\u003e\u003c\/path\u003e\u003cpath d=\"M8 3h8\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eResearch applications\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003eLong-acting GHRH receptor agonism and sustained GH axis stimulation\u003c\/li\u003e\n\u003cli\u003eAlbumin-binding drug delivery mechanism studies\u003c\/li\u003e\n\u003cli\u003eSustained IGF-1 production research\u003c\/li\u003e\n\u003cli\u003eComparison of continuous vs pulsatile GH release pharmacology\u003c\/li\u003e\n\u003cli\u003eWeekly dosing protocol research models\u003c\/li\u003e\n\u003cli\u003eHalf-life extension technology in peptide therapeutics\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/section\u003e\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M3 21V10M9 21V4M15 21v-8M21 21V8\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eResearch protocol reference\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eDose levels referenced by the MVLabs peptide calculator, shown for research reference only:\u003c\/p\u003e\n\u003cdiv class=\"mvd__proto\"\u003e\n\u003cdiv\u003e\n\u003cspan\u003eStarting dose\u003c\/span\u003e\u003cb\u003e1 mg\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cspan\u003eMaintenance\u003c\/span\u003e\u003cb\u003e1–2 mg\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cspan\u003eFrequency\u003c\/span\u003e\u003cb\u003eCada 1–2 semanas\u003c\/b\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp class=\"mvd__pnote\"\u003eDAC extends half-life to ~6–8 days. One injection weekly or biweekly.\u003c\/p\u003e\n\u003cp\u003eReconstitute the 5 mg vial in 2 mL of bacteriostatic water (2.5 mg\/mL). Use the calculator for the exact units for your dose.\u003c\/p\u003e\n\u003ca class=\"mvd__btn\" href=\"https:\/\/mvlabs.mx\/pages\/calculadora-de-peptidos\" target=\"_blank\"\u003eOpen the peptide calculator →\u003c\/a\u003e\u003cp class=\"mvd__src\"\u003eResearch reference only — not dosing guidance for human use. Use the calculator for other vials or volumes.\u003c\/p\u003e\u003c\/section\u003e\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M12 2v6M12 8 7 18a2 2 0 0 0 2 3h6a2 2 0 0 0 2-3z\"\u003e\u003c\/path\u003e\u003cpath d=\"M8.5 14h7\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eHandling \u0026amp; storage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSupplied as a lyophilized powder. Store at \u003cb\u003e2–8 °C\u003c\/b\u003e on receipt; protect from heat, light and moisture, and avoid excessive agitation. If reconstitution is required for laboratory work, use sterile technique — bacteriostatic water, or 0.6% acetic acid for low-solubility peptides. Protocols vary by research application.\u003c\/p\u003e\n\u003ca class=\"mvd__btn\" href=\"https:\/\/mvlabs.mx\/pages\/calculadora-de-peptidos\" target=\"_blank\"\u003eUse the peptide calculator →\u003c\/a\u003e\u003c\/section\u003e\u003cdiv class=\"mvd__note\"\u003e\n\u003cstrong\u003eResearch use only.\u003c\/strong\u003e Research-grade, high-purity material (≥98.7% HPLC) supplied strictly for laboratory and analytical purposes. Not for human or animal consumption; not a drug or dietary supplement; not approved by the FDA, EMA or other agencies. To be handled only by qualified professionals in appropriate facilities, under all applicable laws. A certificate of analysis may be available on request.\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MV Labs","offers":[{"title":"10mg","offer_id":44510488789107,"sku":"CD5","price":1200.0,"currency_code":"MXN","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0697\/3577\/6371\/files\/CJC_DAC_Transparency.png?v=1782516010"},{"product_id":"cjc-1295-no-dac","title":"CJC-1295 no DAC","description":"\u003cstyle\u003e.mvd{font-family:Satoshi,system-ui,sans-serif;color:#13242a;line-height:1.62;font-size:15px}.mvd *{box-sizing:border-box}.mvd__chips{display:flex;flex-wrap:wrap;gap:8px;margin:0 0 22px}.mvd__chip{display:inline-flex;align-items:center;gap:7px;background:rgba(255,255,255,.05);border:1px solid rgba(255,255,255,.5);color:#0B6675;font-family:\"JetBrains Mono\",monospace;font-size:12px;font-weight:500;padding:7px 12px;border-radius:100px}.mvd__chip b{color:#0E8294}.mvd__chip--ruo{background:#13242a;color:#cfe8ec}.mvd__hero{display:flex;gap:16px;align-items:center;background:linear-gradient(120deg,rgba(255,255,255,.05),rgba(255,255,255,.02));border:1px solid rgba(255,255,255,.5);border-radius:16px;padding:16px 20px;margin:0 0 24px}.mvd__hero svg{flex:0 0 auto}.mvd__hero p{margin:0;font-size:14.5px;color:#3a4f56}.mvd section{margin:0 0 20px}.mvd__h{display:flex;align-items:center;gap:9px;margin:0 0 9px}.mvd__h svg{flex:0 0 auto;color:#0E8294}.mvd__h h3{font-family:\"Cabinet Grotesk\",sans-serif;font-weight:800;font-size:17px;margin:0;letter-spacing:-.01em}.mvd ul{margin:6px 0 0;padding:0;list-style:none;display:grid;gap:7px}.mvd ul li{position:relative;padding-left:20px;font-size:14.5px;color:#33474e}.mvd ul li::before{content:\"\";position:absolute;left:2px;top:8px;width:7px;height:7px;border-radius:50%;background:#15a0b4}.mvd p{margin:0 0 10px}.mvd__btn{display:inline-flex;align-items:center;gap:8px;background:#0E8294;color:#fff;font-weight:700;text-decoration:none;padding:11px 18px;border-radius:100px;font-size:14px;margin-top:4px}.mvd__note{background:rgba(255,255,255,.04);border:1px solid rgba(255,255,255,.45);border-radius:14px;padding:16px 18px;font-size:13.5px;color:#51646B}.mvd__note strong{color:#13242a}@media(max-width:520px){.mvd__hero{flex-direction:column;text-align:center}}.mvd__cmp{display:grid;gap:11px;margin:4px 0 12px}.mvd__cmprow{display:grid;grid-template-columns:135px 1fr 52px;align-items:center;gap:12px}.mvd__cmpname{font-size:13px;font-weight:700;color:#13242a}.mvd__cmpname small{display:block;font-weight:500;color:#7c8a90;font-size:10.5px;font-family:\"JetBrains Mono\",monospace}.mvd__cmptrack{height:13px;border-radius:100px;background:rgba(255,255,255,.14);overflow:hidden}.mvd__cmpfill{height:100%;border-radius:100px;background:linear-gradient(90deg,#0E8294,#15a0b4)}.mvd__cmprow--muted .mvd__cmpfill{background:#aac9d0}.mvd__cmpval{font-family:\"JetBrains Mono\",monospace;font-weight:500;font-size:13px;color:#0B6675;text-align:right}.mvd__src{font-size:11.5px;color:#809096;margin-top:-2px}.mvd__proto{display:grid;grid-template-columns:repeat(3,1fr);gap:10px;margin:2px 0 14px}.mvd__proto div{background:rgba(255,255,255,.06);border:1px solid rgba(255,255,255,.5);border-radius:13px;padding:12px 14px}.mvd__proto span{display:block;font-family:\"JetBrains Mono\",monospace;font-size:10.5px;letter-spacing:.06em;text-transform:uppercase;color:#7c8f95;margin-bottom:6px}.mvd__proto b{font-family:\"Cabinet Grotesk\",sans-serif;font-weight:800;font-size:14.5px;color:#0B6675}.mvd__pnote{background:rgba(255,255,255,.05);border:1px solid rgba(255,255,255,.45);border-radius:13px;padding:12px 15px;font-size:13.5px;color:#51646B;margin:0 0 14px}.mvd__ptbl{width:100%;border-collapse:collapse;margin:2px 0 10px;font-size:13.5px}.mvd__ptbl th{text-align:left;font-family:\"JetBrains Mono\",monospace;font-size:10.5px;letter-spacing:.04em;text-transform:uppercase;color:#0E8294;font-weight:600;padding:8px 10px;border-bottom:1px solid rgba(255,255,255,.5)}.mvd__ptbl td{padding:9px 10px;border-bottom:1px solid rgba(255,255,255,.3);color:#33474e}.mvd__ptbl td b{color:#13242a}.mvd__ptbl tr:last-child td{border-bottom:0}@media(max-width:520px){.mvd__proto{grid-template-columns:1fr}}\u003c\/style\u003e\u003cdiv class=\"mvd\"\u003e\n\u003cdiv class=\"mvd__chips\"\u003e\n\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003ePurity\u003c\/b\u003e ≥98.7% HPLC\u003c\/span\u003e\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003eFormat\u003c\/b\u003e Lyophilized powder\u003c\/span\u003e\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003e10 mg \/ vial\u003c\/b\u003e\u003c\/span\u003e\u003cspan class=\"mvd__chip\"\u003e\u003cb\u003eSKU\u003c\/b\u003e CND10\u003c\/span\u003e\u003cspan class=\"mvd__chip mvd__chip--ruo\"\u003eResearch use only\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"mvd__hero\"\u003e\n\u003csvg width=\"74\" height=\"62\" viewbox=\"0 0 74 62\" fill=\"none\"\u003e\u003crect x=\"10\" y=\"40\" width=\"11\" height=\"14\" rx=\"2\" fill=\"#9cc6cd\"\u003e\u003c\/rect\u003e\u003crect x=\"28\" y=\"28\" width=\"11\" height=\"26\" rx=\"2\" fill=\"#15a0b4\"\u003e\u003c\/rect\u003e\u003crect x=\"46\" y=\"14\" width=\"11\" height=\"40\" rx=\"2\" fill=\"#0E8294\"\u003e\u003c\/rect\u003e\u003cpath d=\"M12 18 36 10 64 4\" stroke=\"#0B6675\" stroke-width=\"2.4\" fill=\"none\"\u003e\u003c\/path\u003e\u003cpath d=\"M58 3l7 1-2 7\" stroke=\"#0B6675\" stroke-width=\"2.4\" fill=\"none\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003cp\u003eStudied in the growth-hormone \/ GH–IGF-1 axis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003ccircle cx=\"12\" cy=\"12\" r=\"9\"\u003e\u003c\/circle\u003e\u003cpath d=\"M12 7v10M7 12h10\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCJC-1295 without DAC (also known as Modified GRF 1-29, or Mod-GRF 1-29) is a stabilized truncated analog of GHRH(1-29) incorporating four strategic amino acid substitutions (at positions 2, 8, 15, and 27) that protect against enzymatic degradation by dipeptidyl peptidase IV (DPP-IV) and other proteases. Unlike its DAC counterpart, it retains a physiological half-life of approximately 30 minutes.\u003c\/p\u003e \u003cp\u003eThis shorter duration mimics the natural pulsatile secretion pattern of endogenous GHRH and is commonly co-administered with GHRP compounds such as Ipamorelin. The combination is studied for producing synergistic GH pulses that more closely mirror physiological GH secretion patterns compared to long-acting analogs.\u003c\/p\u003e\u003c\/section\u003e\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M9 3v6l-5 9a2 2 0 0 0 2 3h12a2 2 0 0 0 2-3l-5-9V3\"\u003e\u003c\/path\u003e\u003cpath d=\"M8 3h8\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eResearch applications\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003eShort-acting GHRH receptor agonism and pulsatile GH release\u003c\/li\u003e\n\u003cli\u003eDPP-IV-resistant GHRH analog pharmacokinetic studies\u003c\/li\u003e\n\u003cli\u003eCJC-1295\/Ipamorelin combination protocol research\u003c\/li\u003e\n\u003cli\u003eComparison of pulsatile vs continuous GH stimulation models\u003c\/li\u003e\n\u003cli\u003eIGF-1 axis modulation and downstream signaling\u003c\/li\u003e\n\u003cli\u003eGHRH analog proteolytic stability research\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/section\u003e\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M3 21V10M9 21V4M15 21v-8M21 21V8\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eResearch protocol reference\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eDose levels referenced by the MVLabs peptide calculator, shown for research reference only:\u003c\/p\u003e\n\u003cdiv class=\"mvd__proto\"\u003e\n\u003cdiv\u003e\n\u003cspan\u003eStarting dose\u003c\/span\u003e\u003cb\u003e0.1 mg\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cspan\u003eMaintenance\u003c\/span\u003e\u003cb\u003eHasta 0.2 mg\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cspan\u003eFrequency\u003c\/span\u003e\u003cb\u003e2–3×\/día · en ayunas\u003c\/b\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp class=\"mvd__pnote\"\u003eShort-acting GHRH analog (~30 min). Best paired with Ipamorelin.\u003c\/p\u003e\n\u003cp\u003eReconstitute the 10 mg vial in 10 mL of bacteriostatic water (1 mg\/mL). Use the calculator for the exact units for your dose.\u003c\/p\u003e\n\u003ca class=\"mvd__btn\" href=\"https:\/\/mvlabs.mx\/pages\/calculadora-de-peptidos\" target=\"_blank\"\u003eOpen the peptide calculator →\u003c\/a\u003e\u003cp class=\"mvd__src\"\u003eResearch reference only — not dosing guidance for human use. Use the calculator for other vials or volumes.\u003c\/p\u003e\u003c\/section\u003e\u003csection\u003e\u003cdiv class=\"mvd__h\"\u003e\n\u003csvg width=\"18\" height=\"18\" viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\u003cpath d=\"M12 2v6M12 8 7 18a2 2 0 0 0 2 3h6a2 2 0 0 0 2-3z\"\u003e\u003c\/path\u003e\u003cpath d=\"M8.5 14h7\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003ch3\u003eHandling \u0026amp; storage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSupplied as a lyophilized powder. Store at \u003cb\u003e2–8 °C\u003c\/b\u003e on receipt; protect from heat, light and moisture, and avoid excessive agitation. If reconstitution is required for laboratory work, use sterile technique — bacteriostatic water, or 0.6% acetic acid for low-solubility peptides. Protocols vary by research application.\u003c\/p\u003e\n\u003ca class=\"mvd__btn\" href=\"https:\/\/mvlabs.mx\/pages\/calculadora-de-peptidos\" target=\"_blank\"\u003eUse the peptide calculator →\u003c\/a\u003e\u003c\/section\u003e\u003cdiv class=\"mvd__note\"\u003e\n\u003cstrong\u003eResearch use only.\u003c\/strong\u003e Research-grade, high-purity material (≥98.7% HPLC) supplied strictly for laboratory and analytical purposes. Not for human or animal consumption; not a drug or dietary supplement; not approved by the FDA, EMA or other agencies. To be handled only by qualified professionals in appropriate facilities, under all applicable laws. A certificate of analysis may be available on request.\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MV Labs","offers":[{"title":"10 mg","offer_id":44510488821875,"sku":"CND10","price":4200.0,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0697\/3577\/6371\/files\/CJCnodacTransparency.png?v=1782383479"}],"url":"https:\/\/mvlabs.mx\/collections\/peptidos-glp1-mexico.oembed","provider":"MV Labs","version":"1.0","type":"link"}